VOGS - GM 2/0.3
Composition of :
Each uncoated bilayered tablets contains:
Voglibose IP ......................................... 0.3 mg
Glimepiride IP .................................... 2 mg
Metformin Hydrochloride IP .......... 500 mg
(as sustained release form)
Recipients q.s.
Each uncoated bilayered tablets contains:
Voglibose IP ......................................... 0.3 mg
Glimepiride IP .................................... 2 mg
Metformin Hydrochloride IP .......... 500 mg
(as sustained release form)
Recipients q.s.
Colour : Quinoline Yellow
Dosage : As directed by the Physician.
Store protected from light & moisture at a temperature not exceeding 25℃.
Marketed by :
SYSTOPIC LABORATORIES PVT. LTD.
New Delhi - 110 008
Uses -
It is used to treat high blood sugar level that are caused by a type of diabetes mellitus or sugar diabetes called type 2 diabetes. With this type of diabetes, insulin produced by the pancreas is not able to get sugar into the cells of the body where it can work properly.
Voglibose is an alpha - glucosidase inhibitor used for lowering post - pradip blood glucose level in people with diabetes mellitus.

0 Comments